Molecular Mechanisms of Cross-talk between Thyroid Hormone and Peroxisome Proliferator Activated Receptors: Focus on the Heart

Author： Hyyti Outi   Portman Michael  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.20, Iss.6, 2006-12, pp. : 463-469

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator activated receptors and obesity

By Kersten S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors as New Molecular Targets in Psoriasis

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 2, 2004-06 ,pp. : 205-211

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptors and the Control of Inflammation Update

By  

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 3, 2004-07 ,pp. : 297-298

Bentham Science Publishers

Access to resources Recommend Favorite

Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)

By  

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-06 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes

By ŠŠeda Ondøøřřej   ŠŠedováá Lucie  

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 587-596

Future Medicine

Access to resources Recommend Favorite